Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 105

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9B
Chunk 105
---
 since June 2020 on a variety of financial and strategic initiatives. Previously he
was a Senior Advisor and Head of Global Healthcare at GCA Global from 2005 to 2019, an investment bank providing strategic M&A and
capital markets advice for growth companies. From 1994 to 2004 he was Head of Research for Vector Securities with over 200 companies
under coverage and later became Head of Capital Markets that acquired by Prudential Securities. From 1990 to 1993 Mr. Kirsch was CEO
OF Natwest Markets the investment banking division of Natwest Bank in the U.K. He began his career at Drexel Burnham where he was an
Executive Vice President running the global equity division as well as being on the Executive Committee. Mr. Kirsch has served on the
Board of Kadmon since 2019, a publicly traded bio pharmaceutical company where he serves on the Audit Committee. He also serves on the
board of Liquidia Technologies a public nano technology healthcare company as well as being the Chairman of the Audit Committee. Mr.
Kirsch received his B.A. in Finance from the University of Rhode Island and an M.B.A. from Bernard M. Baruch College.

Mark
Dant. Mr. Dant, EveryLife Foundation for Rare Diseases Board Chair, is a parent advocate and retired Carrolton, Texas Police
Department Chief of Police. Mark and his wife Jeanne are the parents of Ryan, who is 33 years old and the longest treated person in the
world with MPS I. Mark and Jeanne spearheaded the funding for the first MPS Enzyme Replacement Therapy, Aldurazyme, through their Foundation,
the Ryan Foundation. In partnership with Dr. Emil Kakkis, Mr. Dant and his family were also key advocates speaking to the FDA about the
importance and significant impact of ERT for the treatment of mucopolysaccharidoses. In 2009, Mr. Dant and his family successfully championed
Congress to pass the Ryan Dant Health Care Opportunity Act, H.R. 1441-111.

99

Family
Relationships

There
are no family relationships among any of our directors or executive officers, except that Christer Rosén, our Chief Executive
Officer, is the father of Alexander Rosén, our Chief Administrative Officer.

Involvement
in Certain Legal Proceedings

No
executive officer, member of the board of directors or control person of our Company has been involved